Immatics (IMTX) Change in Receivables (2019 - 2025)
Immatics (IMTX) posted Change in Receivables of -$3.4 million for Q4 2025, down 133.62% sequentially from -$1.4 million in Q3 2025, and down 8.71% YoY from -$3.7 million in Q4 2024.
Immatics (IMTX) Change in Receivables (2019 - 2025) Analysis & Trends
Immatics has reported Change in Receivables for 7 years, with the latest figure at -$3.4 million in Q4 2025.
- Quarterly Change in Receivables fell 8.71% year-over-year to -$3.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$433406.6 (up 76.66% YoY) and the FY2025 annual result came in at -$273414.3, up 85.68% from the prior year.
- Change in Receivables slipped to -$3.4 million in Q4 2025 per IMTX's latest filing, from -$1.4 million in the prior quarter.
- Over five years, Change in Receivables peaked at $4.1 million in Q2 2025 and troughed at -$3.8 million in Q4 2023.
- A 5-year average of -$263618.7 and a median of -$131326.2 in 2024 frame the typical range for Change in Receivables.
- The widest YoY moves for Change in Receivables: up 1479.64% in 2023, down 13576.12% in 2023.
- Over 5 years, Change in Receivables stood at $50334.7 in 2021, then slumped by 43.25% to $28566.9 in 2022, then slumped by 13576.12% to -$3.8 million in 2023, then climbed by 19.34% to -$3.1 million in 2024, then declined by 8.71% to -$3.4 million in 2025.
- According to Business Quant data, Change in Receivables over the past three periods registered -$3.4 million, -$1.4 million, and $4.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 117.58 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -483,662.49 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 31.60 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 37.16 Mn |
| 10 | Immatics | 1.27 Bn | 719.31 Mn | - | -3.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.38 Mn |
| Dec 31, 2025 | -3.38 Mn |
| Sep 30, 2025 | -1.44 Mn |
| Sep 30, 2025 | -1.44 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Jun 30, 2025 | 4.12 Mn |
| Mar 31, 2025 | 270,334.30 |
| Mar 31, 2025 | 270,334.30 |
| Dec 31, 2024 | -3.11 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Sep 30, 2024 | -154,848.95 |
| Sep 30, 2024 | -154,848.95 |
| Jun 30, 2024 | -1.11 Mn |
| Jun 30, 2024 | -1.11 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | -3.85 Mn |
| Dec 31, 2023 | -3.85 Mn |
| Sep 30, 2023 | -201,389.24 |
| Sep 30, 2023 | -201,389.24 |